Solupore® Integrated, Cell Therapy Manufacturing Platform 

Driving scalable and affordable cell therapy, Avectas is transforming manufacturing with Solupore®, a flexible, integrated manufacturing platform that enables affordable cell therapies.

We have built on our best-in class non-viral transfection process to integrate additional unit processes into the same consumable and have developed a closed system that enables both viral and non-viral CAR-T workflows.

With barriers to commercialization, including labor-intensive workflows, high capital requirements for GMP facilities, fragmented processes, and a need for multiple single-use platforms, Solupore offers a scalable, GMP compliant integrated solution.

By shifting from single-use instruments to scale-out simplicity, reducing manual touchpoints, and delivering platforms that are intuitive and flexible, Avectas accelerates the clinical translation of life-saving therapies and unlocks the full potential of next-generation cell engineering.